How new medicines get approved and finally reach patients today
Approved does not always mean available. This guide explains how the FDA, MHRA and EMA review medicines, how NICE decides NHS funding, and why countries differ.
8 October 2026
Clinical trials, drug development and research news
Tag
Approved does not always mean available. This guide explains how the FDA, MHRA and EMA review medicines, how NICE decides NHS funding, and why countries differ.
8 October 2026
The EMA says the proposed Biotech Act affects about 70% of the EU clinical trials system, with first changes possible in 2028 as the FAST-EU pilot tests 70-day approvals.
1 October 2026
The Council has adopted the biggest rewrite of EU medicines law in two decades, changing protection periods, orphan exclusivity, antibiotic incentives and EMA review times.
28 September 2026